Smoldering and polarized inflammation in the initiation and promotion of malignant disease

被引:1463
作者
Balkwill, F [1 ]
Charles, KA
Mantovani, A
机构
[1] Barts & London Queen Marys Med Sch, Translat Oncol Lab, Canc Res UK, London EC1M 6BQ, England
[2] Ist Ric Farmacol Mario Negri, Dept Immunol & Cell Biol, I-20157 Milan, Italy
[3] Univ Milan, I-20157 Milan, Italy
关键词
D O I
10.1016/j.ccr.2005.02.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:211 / 217
页数:7
相关论文
共 83 条
  • [1] Interleukin 1-dependent and -independent mouse melanoma metastases
    Anasagasti, MJ
    Olaso, E
    Calvo, F
    Mendoza, L
    Martin, JJ
    Bidaurrazaga, J
    VidalVanaclocha, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (09) : 645 - 651
  • [2] Interleukin-1 - a major pleiotropic cyrtokine in tumor-host interactions
    Apte, RN
    Voronov, E
    [J]. SEMINARS IN CANCER BIOLOGY, 2002, 12 (04) : 277 - 290
  • [3] Tumour necrosis factor-α mediates tumour promotion via a PKCα- and AP-1-dependent pathway
    Arnott, CH
    Scott, KA
    Moore, RJ
    Hewer, A
    Phillips, DH
    Parker, P
    Balkwill, FR
    Owens, DM
    [J]. ONCOGENE, 2002, 21 (31) : 4728 - 4738
  • [4] Expression of both TNF-α receptor subtypes is essential for optimal skin tumour development
    Arnott, CH
    Scott, KA
    Moore, RJ
    Robinson, SC
    Thompson, RG
    Balkwill, FR
    [J]. ONCOGENE, 2004, 23 (10) : 1902 - 1910
  • [5] Interleukin-1β inhibits CAR-induced expression of hepatic genes involved in drug and bilirubin clearance
    Assenat, E
    Gerbal-Chaloin, S
    Larrey, D
    Saric, J
    Fabre, JM
    Maurel, P
    Vilarem, MJ
    Pascussi, JM
    [J]. HEPATOLOGY, 2004, 40 (04) : 951 - 960
  • [6] Tumor necrosis factor or tumor promoting factor?
    Balkwill, F
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 2002, 13 (02) : 135 - 141
  • [7] Inflammation and cancer: back to Virchow?
    Balkwill, F
    Mantovani, A
    [J]. LANCET, 2001, 357 (9255) : 539 - 545
  • [8] BALKWILL FR, 2004, IN PRESS NAT REV CAN
  • [9] BIOLOGIC EFFECTS OF ANTI-INTERLEUKIN-6 MURINE MONOCLONAL-ANTIBODY IN ADVANCED MULTIPLE-MYELOMA
    BATAILLE, R
    BARLOGIE, B
    LU, ZY
    ROSSI, JF
    LAVABREBERTRAND, T
    BECK, T
    WIJDENES, J
    BROCHIER, J
    KLEIN, B
    [J]. BLOOD, 1995, 86 (02) : 685 - 691
  • [10] TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling
    Becker, C
    Fantini, MC
    Schramm, C
    Lehr, HA
    Wirtz, S
    Nikolaev, A
    Burg, J
    Strand, S
    Kiesslich, R
    Huber, S
    Ito, H
    Nishimoto, N
    Yoshizaki, K
    Nishimoto, N
    Galle, PR
    Blessing, M
    Rose-John, S
    Neurath, MF
    [J]. IMMUNITY, 2004, 21 (04) : 491 - 501